IBDEI1KR ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,25166,1,3,0)
 ;;=3^Osteomyelitis w/ Draining Sinus,Chronic,Unspec Site
 ;;^UTILITY(U,$J,358.3,25166,1,4,0)
 ;;=4^M86.40
 ;;^UTILITY(U,$J,358.3,25166,2)
 ;;=^5014583
 ;;^UTILITY(U,$J,358.3,25167,0)
 ;;=R50.2^^107^1213^23
 ;;^UTILITY(U,$J,358.3,25167,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25167,1,3,0)
 ;;=3^Fever,Drug-Induced
 ;;^UTILITY(U,$J,358.3,25167,1,4,0)
 ;;=4^R50.2
 ;;^UTILITY(U,$J,358.3,25167,2)
 ;;=^5019507
 ;;^UTILITY(U,$J,358.3,25168,0)
 ;;=R50.9^^107^1213^27
 ;;^UTILITY(U,$J,358.3,25168,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25168,1,3,0)
 ;;=3^Fever,Unspec
 ;;^UTILITY(U,$J,358.3,25168,1,4,0)
 ;;=4^R50.9
 ;;^UTILITY(U,$J,358.3,25168,2)
 ;;=^5019512
 ;;^UTILITY(U,$J,358.3,25169,0)
 ;;=R76.11^^107^1213^1
 ;;^UTILITY(U,$J,358.3,25169,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25169,1,3,0)
 ;;=3^Abnormal Reaction to TB Test w/o Active TB
 ;;^UTILITY(U,$J,358.3,25169,1,4,0)
 ;;=4^R76.11
 ;;^UTILITY(U,$J,358.3,25169,2)
 ;;=^5019570
 ;;^UTILITY(U,$J,358.3,25170,0)
 ;;=Z21.^^107^1213^30
 ;;^UTILITY(U,$J,358.3,25170,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25170,1,3,0)
 ;;=3^HIV Asymptomatic,Infection Status
 ;;^UTILITY(U,$J,358.3,25170,1,4,0)
 ;;=4^Z21.
 ;;^UTILITY(U,$J,358.3,25170,2)
 ;;=^5062777
 ;;^UTILITY(U,$J,358.3,25171,0)
 ;;=B37.0^^107^1213^16
 ;;^UTILITY(U,$J,358.3,25171,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25171,1,3,0)
 ;;=3^Candidal Stomatitis (Oral Thrush)
 ;;^UTILITY(U,$J,358.3,25171,1,4,0)
 ;;=4^B37.0
 ;;^UTILITY(U,$J,358.3,25171,2)
 ;;=^5000612
 ;;^UTILITY(U,$J,358.3,25172,0)
 ;;=B97.10^^107^1213^22
 ;;^UTILITY(U,$J,358.3,25172,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25172,1,3,0)
 ;;=3^Enterovirus,Unspec,as Cause of Disease
 ;;^UTILITY(U,$J,358.3,25172,1,4,0)
 ;;=4^B97.10
 ;;^UTILITY(U,$J,358.3,25172,2)
 ;;=^5000861
 ;;^UTILITY(U,$J,358.3,25173,0)
 ;;=R50.82^^107^1213^24
 ;;^UTILITY(U,$J,358.3,25173,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25173,1,3,0)
 ;;=3^Fever,Postprocedural
 ;;^UTILITY(U,$J,358.3,25173,1,4,0)
 ;;=4^R50.82
 ;;^UTILITY(U,$J,358.3,25173,2)
 ;;=^5019509
 ;;^UTILITY(U,$J,358.3,25174,0)
 ;;=R50.83^^107^1213^26
 ;;^UTILITY(U,$J,358.3,25174,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25174,1,3,0)
 ;;=3^Fever,Postvaccination
 ;;^UTILITY(U,$J,358.3,25174,1,4,0)
 ;;=4^R50.83
 ;;^UTILITY(U,$J,358.3,25174,2)
 ;;=^5019510
 ;;^UTILITY(U,$J,358.3,25175,0)
 ;;=R50.84^^107^1213^25
 ;;^UTILITY(U,$J,358.3,25175,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25175,1,3,0)
 ;;=3^Fever,Posttransfusion
 ;;^UTILITY(U,$J,358.3,25175,1,4,0)
 ;;=4^R50.84
 ;;^UTILITY(U,$J,358.3,25175,2)
 ;;=^5019511
 ;;^UTILITY(U,$J,358.3,25176,0)
 ;;=B02.23^^107^1213^70
 ;;^UTILITY(U,$J,358.3,25176,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25176,1,3,0)
 ;;=3^Postherpetic Polyneuropathy
 ;;^UTILITY(U,$J,358.3,25176,1,4,0)
 ;;=4^B02.23
 ;;^UTILITY(U,$J,358.3,25176,2)
 ;;=^266550
 ;;^UTILITY(U,$J,358.3,25177,0)
 ;;=B02.22^^107^1213^71
 ;;^UTILITY(U,$J,358.3,25177,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25177,1,3,0)
 ;;=3^Postherpetic Trigeminal Neuralgia
 ;;^UTILITY(U,$J,358.3,25177,1,4,0)
 ;;=4^B02.22
 ;;^UTILITY(U,$J,358.3,25177,2)
 ;;=^266546
 ;;^UTILITY(U,$J,358.3,25178,0)
 ;;=J03.91^^107^1213^80
 ;;^UTILITY(U,$J,358.3,25178,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25178,1,3,0)
 ;;=3^Tonsillitis,Acute Recurrent,Unspec
 ;;^UTILITY(U,$J,358.3,25178,1,4,0)
 ;;=4^J03.91
